Finance
Markets
No recent trading data. The last price we hold for AMGN is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

AMGN

stock Healthcare Drug Manufacturers - General
Amgen
$338.22 +9.96 (+3.03%) Delayed · quoted 46d ago
Healthy 79% Climbing

What the indicators say

Mixed 3 of 5 trend signals bullish
Momentum · RSI 14 Neutral
52
0oversold 30overbought 70100

RSI 52 — momentum is balanced between buyers and sellers.

EMA 21 $334.95
Above
Near-term trend is up
SMA 50 $340.83
Below
Medium-term trend is down
SMA 200 $328.83
Above
Long-term trend is up
50 / 200-day
Golden cross
50-day above the 200-day — bullish
Supertrend $345.96
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $325.98 High $338.70
Open
$338.22
+3.03%
Close
$338.22
+3.03%
52-week range where the price sits across its year
52w low $267.83 52w high $391.29
Current
$338.22
Prev close
$328.26
Volume 0.86× the 3-month average
0 avg 2× avg
Today
2.21M
3-mo avg
2.58M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 3082 days ago
Next expected
Aug 4in 14 days

Recent earnings dates

  • Apr 30 82 days ago
  • Feb 3 168 days ago
  • Nov 4, 2025 259 days ago
  • Aug 5, 2025 350 days ago

Past earnings dates come from AMGN’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 53d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), AMGN’s fundamentals read as strong overall.

P/E ratio Strong
23.5x

At 23.5x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Strong
2.86%

A 2.9% yield is a healthy, generally sustainable level of cash income.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Strong
21.0%

A 21.0% margin is strong; the company keeps a healthy slice of every revenue dollar.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong
89.1%

A 89.1% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Strong
8.5%

A 8.5% return on assets is strong; the company squeezes good profit from its assets.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data
—

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.14

At 1.14, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+10.0%

Revenue grew 10.0% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Strong
+88.5%

Net income grew 88.5% from the prior year: strong profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 53d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $26.0B$26.3B$28.2B$33.4B$36.8B
Net income $5.9B$6.6B$6.7B$4.1B$7.7B
Diluted EPS $10.28$12.11$12.49$7.56$14.23
Dividend / share $7.22$7.95$8.64$9.13$9.66
Total assets $61.2B$65.1B$97.2B$91.8B$90.6B
Total liabilities —————
Shareholder equity $6.7B$3.7B$6.2B$5.9B$8.7B

Leadershipsynced from SEC 59d ago

  • Bradway Robert A Chairman, CEO and President · Director
  • Griffith Peter H. EVP & CFO
  • Bradner James E. EVP, Research and Development
  • Busch Matthew C. VP, Finance & CAO
  • Gordon Murdo EVP, Global Commercial Ops
  • Graham Jonathan P EVP & Gen. Counsel & Sec.
  • Grygiel Nancy A. SVP & CCO
  • Khosla Rachna SVP, Business Development
  • Miller Derek SVP, Human Resources
  • Reese David M EVP & Chief Technology Officer
  • Santos Esteban EVP, Operations
  • Austin Wanda M Director
  • Drake Michael V Director
  • Druker Brian Director
  • Eckert Robert Director
  • Garland Greg C. Director
  • Holley Charles M Director
  • Ishrak Omar Director
  • Jacks Tyler Director
  • Klotman Mary E. Director
  • Kullman Ellen Jamison Director
  • Miles Amy E Director

Officers and board are drawn from AMGN’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$9.52
2026 so far
$5.042 payments
2026 projected
$10.08+5.9% vs 2025

Projection scales AMGN’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • May 15 $2.52
  • Feb 13 $2.52
  • Nov 21, 2025 $2.38
  • Aug 22, 2025 $2.38
  • May 16, 2025 $2.38
  • Feb 14, 2025 $2.38
  • Nov 18, 2024 $2.25
  • Aug 16, 2024 $2.25
  • May 16, 2024 $2.25
  • Feb 15, 2024 $2.25
  • Nov 16, 2023 $2.13
  • Aug 17, 2023 $2.13
  • May 17, 2023 $2.13
  • Feb 14, 2023 $2.13
  • Nov 16, 2022 $1.94
  • Aug 17, 2022 $1.94
  • May 16, 2022 $1.94
  • Feb 14, 2022 $1.94
  • Nov 15, 2021 $1.76
  • Aug 16, 2021 $1.76

Recent SEC filingssynced from SEC 53d ago

© 2026 Isaac Bythewood · Some rights reserved